Oil prices increased as investors considered the risk of renewed military conflict between the US and Iran following the US midterm elections, alongside emerging hopes for a diplomatic solution. Brent crude rose to $99.90 per barrel and US West Texas Intermediate to $91.69 per barrel. Analysts, including Rapidan Energy's Bob McNally, see an 80% chance of military fighting resuming, which could push prices above $100. Meanwhile, Iran reportedly sent a nuclear proposal to the US via Qatar, offering a potential path to ease tensions. Continued attacks on oil tankers in the Strait of Hormuz add to the uncertainty in the oil market.
Oil prices and geopolitical risks in the U.S.-Iran context provide relevant market background. For readers following energy stocks, here is Pluang's market snapshot as of Nov 06, 2026 12:02 WIB: Among 79 priced Energy-sector US stocks, 4 rose and 75 fell. Notable movers include SEI at USD 51.34 with a -10.93% change and a typical hold time of 7 days, NESR at USD 19.16 down -10.84% with an 8-day hold, and RUN at USD 9.74 up 10.81% with a 16-day hold and 58% sell order activity.
The 2026 Global Health Congress in New York gathered over 625 healthcare leaders from 25 countries to discuss innovation, equity, and investment in healthcare. The event featured 350+ startup applications in its Healthcare Shark Tank competition, cro...
Ambarella, an edge AI semiconductor company, announced its third quarter fiscal year 2027 earnings conference call will be held on November 24, 2026, at 1:30 p.m. Pacific Time. The company will release its earnings report after the market closes that...
Apple Inc. (AAPL) perpetual contracts on Hyperliquid bounced back near $350 on November 5, recovering from recent losses. A wallet added about $33.22 million to a large short position totaling roughly 150,000 contracts valued at $52.46 million, with ...
Kyivstar Group Ltd reported a 17.5% year-on-year revenue increase to USD 349 million in Q3 2026, driven by higher mobile ARPU and data usage. EBITDA rose 10.3% to USD 189 million, and net profit turned positive at USD 99 million after a prior loss. D...
Alphatec Holdings, a leader in the U.S. spinal disorder treatment market, reported disappointing Q3 2026 results and lowered its full-year revenue, Adjusted EBITDA, and free cash flow forecasts. Management cited execution problems and weakening marke...
